Beyond BMI During Neoadjuvant Therapy: Nutritional Phenotyping and Targeted Dietetic Intervention in Locally Advanced Rectal Cancer

Locally advanced rectal cancer is increasingly managed through prolonged neoadjuvant pathways, including total neoadjuvant therapy and, in selected patients, non-operative organ-preservation strategies. Although these approaches have improved opportunities for tumor response and organ preservation, they also extend the period during which nutritional decline, altered bowel function, fatigue, and loss of physiological reserve may occur. Nutritional vulnerability during this interval is heterogeneous and may not be adequately captured by body weight or body mass index alone. This state-of-the-art narrative review examines nutritional phenotypes relevant to patients with locally advanced rectal cancer during neoadjuvant therapy. It first outlines why this interval should be regarded as a period of dynamic nutritional vulnerability. It then summarizes key phenotypes that may inform risk stratification and care, including overt malnutrition, sarcopenia, sarcopenic obesity, myosteatosis, and treatment-related decline. Finally, it proposes a practical framework for phenotype-based assessment and targeted dietetic intervention prior to restaging and definitive management. Current evidence suggests that adverse body-composition change during neoadjuvant therapy may be associated with poorer treatment tolerance, inferior tumor response, and worse oncological outcomes. For dietitians, this supports a shift from one-off screening toward longitudinal assessment that integrates oral intake, symptom burden, body-composition risk, and treatment trajectory. Although intervention evidence remains heterogeneous, nutritional care during neoadjuvant therapy should be proactive, individualized, and embedded within modern rectal cancer pathways.

Authors

Institutions

Publication Details

Journal
Nutrition and Cancer
Published
2026-11-14
DOI
https://doi.org/10.1080/01635581.2026.2762544
Primary Topic
Nutrition and Health in Aging
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Beyond BMI During Neoadjuvant Therapy: Nutritional Phenotyping and Targeted Dietetic Intervention in Locally Advanced Rectal Cancer

James Lim, Vignesh Narasimhan, Belinda Carpenter, Rathin Gosavi et al.
Nutrition and Cancer
Nutrition and Health in Aging
article

Beyond BMI During Neoadjuvant Therapy: Nutritional Phenotyping and Targeted Dietetic Intervention in Locally Advanced Rectal Cancer

James Lim, Vignesh Narasimhan, Belinda Carpenter, Rathin Gosavi, Paul McMurrick, William Teoh, Deanna Newell
article en

Abstract

Locally advanced rectal cancer is increasingly managed through prolonged neoadjuvant pathways, including total neoadjuvant therapy and, in selected patients, non-operative organ-preservation strategies. Although these approaches have improved opportunities for tumor response and organ preservation, they also extend the period during which nutritional decline, altered bowel function, fatigue, and loss of physiological reserve may occur. Nutritional vulnerability during this interval is heterogeneous and may not be adequately captured by body weight or body mass index alone. This state-of-the-art narrative review examines nutritional phenotypes relevant to patients with locally advanced rectal cancer during neoadjuvant therapy. It first outlines why this interval should be regarded as a period of dynamic nutritional vulnerability. It then summarizes key phenotypes that may inform risk stratification and care, including overt malnutrition, sarcopenia, sarcopenic obesity, myosteatosis, and treatment-related decline. Finally, it proposes a practical framework for phenotype-based assessment and targeted dietetic intervention prior to restaging and definitive management. Current evidence suggests that adverse body-composition change during neoadjuvant therapy may be associated with poorer treatment tolerance, inferior tumor response, and worse oncological outcomes. For dietitians, this supports a shift from one-off screening toward longitudinal assessment that integrates oral intake, symptom burden, body-composition risk, and treatment trajectory. Although intervention evidence remains heterogeneous, nutritional care during neoadjuvant therapy should be proactive, individualized, and embedded within modern rectal cancer pathways.

Nutrition and Cancer
Cabrini Hospital (AU), Monash Health (AU), Monash University (AU)
Nutrition and Health in Aging
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon